Literature DB >> 22341562

Critical role of the NOTCH ligand JAG2 in self-renewal of myeloma cells.

David Chiron1, Sophie Maïga, Géraldine Descamps, Philippe Moreau, Steven Le Gouill, Séverine Marionneau, Thibauld Ouiller, Jérôme Moreaux, Bernard Klein, Régis Bataille, Martine Amiot, Catherine Pellat-Deceunynck.   

Abstract

The purpose of this study was to identify the pathways associated with the ability of CD138(+) human myeloma cells to form colonies in a serum-free semi-solid human collagen-based assay. Only 26% (7 of 27) of human myeloma cell lines were able to spontaneously form colonies. This spontaneous clonogenic growth correlated with the expression of the NOTCH ligand JAG2 (p<0.001). Blocking JAG-NOTCH interactions with NOTCH-Fc chimeric molecules impaired self-colony formation, indicating a role for JAG-NOTCH pathway in colony formation. In two cell lines, silencing of JAG2 blocked both colony formation and in vivo tumor formation in immunocompromised mice. RT-PCR and flow cytometry analysis revealed that JAG2 is often expressed by CD138(+) primary cells. Our results indicate that spontaneous clonogenic growth of myeloma cells requires the expression of JAG2. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22341562     DOI: 10.1016/j.bcmd.2012.01.006

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  11 in total

1.  Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma.

Authors:  Jesus Delgado-Calle; Judith Anderson; Meloney D Cregor; Masahiro Hiasa; John M Chirgwin; Nadia Carlesso; Toshiyuki Yoneda; Khalid S Mohammad; Lilian I Plotkin; G David Roodman; Teresita Bellido
Journal:  Cancer Res       Date:  2016-02-01       Impact factor: 12.701

2.  Autocrine insulin-like growth factor 1 and stem cell factor but not interleukin 6 support self-renewal of human myeloma cells.

Authors:  D Chiron; S Maïga; S Surget; G Descamps; P Gomez-Bougie; S Traore; N Robillard; P Moreau; S Le Gouill; R Bataille; M Amiot; C Pellat-Deceunynck
Journal:  Blood Cancer J       Date:  2013-06-07       Impact factor: 11.037

Review 3.  Fact or fiction--identifying the elusive multiple myeloma stem cell.

Authors:  Joshua Kellner; Bei Liu; Yubin Kang; Zihai Li
Journal:  J Hematol Oncol       Date:  2013-12-07       Impact factor: 17.388

4.  Notch pathway inhibition controls myeloma bone disease in the murine MOPC315.BM model.

Authors:  R Schwarzer; N Nickel; J Godau; B M Willie; G N Duda; R Schwarzer; B Cirovic; A Leutz; R Manz; B Bogen; B Dörken; F Jundt
Journal:  Blood Cancer J       Date:  2014-06-13       Impact factor: 11.037

5.  Identification of small molecules uncoupling the Notch::Jagged interaction through an integrated high-throughput screening.

Authors:  Natalia Platonova; Chiara Parravicini; Cristina Sensi; Alessandro Paoli; Michela Colombo; Antonino Neri; Ivano Eberini; Raffaella Chiaramonte
Journal:  PLoS One       Date:  2017-11-03       Impact factor: 3.240

Review 6.  The Emerging Role of Osteocytes in Cancer in Bone.

Authors:  Emily G Atkinson; Jesús Delgado-Calle
Journal:  JBMR Plus       Date:  2019-02-27

7.  Conserved aging-related signatures of senescence and inflammation in different tissues and species.

Authors:  Emanuel Barth; Akash Srivastava; Milan Stojiljkovic; Christiane Frahm; Hubertus Axer; Otto W Witte; Manja Marz
Journal:  Aging (Albany NY)       Date:  2019-10-12       Impact factor: 5.682

Review 8.  Implications of heterogeneity in multiple myeloma.

Authors:  Sanjay de Mel; Su Hong Lim; Moon Ley Tung; Wee-Joo Chng
Journal:  Biomed Res Int       Date:  2014-07-02       Impact factor: 3.411

Review 9.  Notch signaling deregulation in multiple myeloma: A rational molecular target.

Authors:  Michela Colombo; Serena Galletti; Silvia Garavelli; Natalia Platonova; Alessandro Paoli; Andrea Basile; Elisa Taiana; Antonino Neri; Raffaella Chiaramonte
Journal:  Oncotarget       Date:  2015-09-29

10.  Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche.

Authors:  Michela Colombo; Serena Galletti; Gaetano Bulfamante; Monica Falleni; Delfina Tosi; Katia Todoerti; Elisa Lazzari; Leslie A Crews; Catriona H M Jamieson; Sara Ravaioli; Francesco Baccianti; Silvia Garavelli; Natalia Platonova; Antonino Neri; Raffaella Chiaramonte
Journal:  Oncotarget       Date:  2016-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.